Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

109.91 -0.94 (-0.85%)
Streaming Delayed Price Updated: 12:10 PM EST, Dec 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,564,806
Open 110.98
Bid (Size) 109.90 (3)
Ask (Size) 109.91 (2)
Prev. Close 110.85
Today's Range 109.77 - 111.37
52wk Range 71.97 - 111.02
Shares Outstanding 2,531,374,696
Dividend Yield 2.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors chose Stryker Corporation (NYSE: SYK), saying all medical procedures that 
Via Benzinga
Here's How Much $100 Invested In Merck & Co 5 Years Ago Would Be Worth Today
 
Via Benzinga

Performance

YTD
+42.98%
+42.98%
1 Month
+8.29%
+8.29%
3 Month
+25.73%
+25.73%
6 Month
+24.90%
+24.90%
1 Year
+50.13%
+50.13%

More News

Read More
Why Shares of Mirati Therapeutics Fell Wednesday
Via The Motley Fool
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
Via Benzinga
3 High-Yielding Stocks That Are Up 27%-Plus This Year
Via The Motley Fool
A Look Into Merck & Co's Debt
Via Benzinga
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
Via InvestorPlace
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
Via Investor's Business Daily
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via Globe NewsWire
Will Black Friday Push The S&P 500 Over Its 200DMA?
Via Talk Markets
What Bear Market? This Top-Performing Dow Stock Has Thrived in 2022.
Via The Motley Fool
Should Investors Consider These 3 Low-Beta Stocks?
Via Talk Markets
Merck & Co Unusual Options Activity
Via Benzinga
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
From Merck & Co., Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Merck Announces First-Quarter 2023 Dividend
From Merck & Co., Inc.
Via Business Wire
3 Dow Stocks to Take Seriously in 2023
Via InvestorPlace
Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty
Via Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
Via The Motley Fool
Stocks Take A Hit As Wall Street Eyes China Covid Unrest
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.